Transmission electron microscopic image of an isolate from the first U.S. case of COVID-19, formerly known as 2019-nCoV. The spherical viral particles, colorized blue, contain cross-section through the viral genome, seen as black dots. (CDC)

U.K. Trials Begin for COVID-19 Drug Touted by Trump

Frontline health workers will be able to take part in a clinical trial to see whether a drug touted by Donald Trump can prevent coronavirus. 

It is the first global study testing whether hydroxychloroquine can be used as a prophylactic measure, as opposed to previous ones examining its potential to treat the disease. 

The first U.K. participants will be enrolled from May 21 at Brighton and Sussex University Hospitals and at Oxford’s John Radcliffe Hospital. Further testing is expected at four more sites by the end of May, with 25 total locations opened across the country before July.

Read more at Metro

(Visited 27 times, 1 visits today)

The Government Technology & Services Coalition's Homeland Security Today (HSToday) is the premier news and information resource for the homeland security community, dedicated to elevating the discussions and insights that can support a safe and secure nation. A non-profit magazine and media platform, HSToday provides readers with the whole story, placing facts and comments in context to inform debate and drive realistic solutions to some of the nation’s most vexing security challenges.

Leave a Reply

Latest from Coronavirus

Go to Top
X
X